Position in EXEL
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,815,576
+$576,283 QoQ
Shares Held
42,331
+49.7% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2023
8 quarters on record
Voting authority
Sole 7.401195341475514.ToString("F0")%
Shared 0.ToString("F0")%
None 92.59880465852449.ToString("F0")%
Common Shares in EXEL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026NewEdge Wealth, LLC holds $20,244,273 across 19 Biotechnology names. EXEL ranks #4 (9.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
9,788 | $4,370,733 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
9,201 | $3,044,334 | |
| 3 | BHVN |
Biohaven Ltd.
|
246,503 | $2,085,415 | |
| 4 | EXEL |
Exelixis, Inc.
This page
|
42,331 | $1,815,576 | |
| 5 | INVA |
Innoviva, Inc.
|
77,134 | $1,797,222 | |
| 6 | CORT |
Corcept Therapeutics Inc
|
27,887 | $1,124,124 | |
| 7 | NVAX |
Novavax Inc
|
130,000 | $1,058,200 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
21,856 | $711,194 |
All Filings in EXEL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,815,576 | 42,331 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,239,293 | 28,275 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $1,050,630 | 25,439 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $912,191 | 20,694 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $427,459 | 11,578 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $346,286 | 10,399 | Shares | Sole | 2025-02-05 | |
| 2023-12-31 | $16,339,684 | 681,104 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $10,237,839 | 468,551 | Shares | Sole | 2023-11-08 | |
| No filing history on record for this holder in this stock. | ||||||